Tahvilian N, Masoodi M, Faghihi Kashani A, et al
We aimed to incorporate items published from 2018 until 2024, which found these particular reports offered significant insights and chose to incorporate them into this review
Ozempic (semaglutide) is a GLP-1 receptor agonist licensed for type 2 diabetes management
The opioid component of delayed gastrointestinal recovery after bowel resection
Metformin itself does not directly interact with tirzepatide at the drug-metabolism level, but both medications require adequate kidney function to work safely
Insufficient protein intake during weight loss might theoretically contribute to muscle discomfort, whilst changes in micronutrient status could affect muscle and joint function, though this requires further research